Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway. [electronic resource]
Producer: 20140930Description: e83013 p. digitalISSN:- 1932-6203
- Animals
- Apoptosis
- Cell Proliferation -- drug effects
- Colitis -- chemically induced
- Depsipeptides -- therapeutic use
- Disease Models, Animal
- Down-Regulation
- Female
- Flow Cytometry
- Gene Expression Regulation, Enzymologic
- Inflammation
- Interferon-gamma -- metabolism
- Lymphocyte Activation -- drug effects
- Membrane Potential, Mitochondrial -- drug effects
- Mice
- Mice, Inbred BALB C
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphorylation
- Proto-Oncogene Proteins c-akt -- metabolism
- Signal Transduction
- T-Lymphocytes -- drug effects
- Trinitrobenzenesulfonic Acid -- chemistry
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.